Drug Shortage Report for SANDOZ DILTIAZEM CD

Last updated on 2019-10-15 History
Report ID 59505
Drug Identification Number 02243339
Brand name SANDOZ DILTIAZEM CD
Common or Proper name DILTIAZEM
Company Name SANDOZ CANADA INCORPORATED
Market Status CANCELLED POST MARKET
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 180MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100S
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-06-08
Estimated end date 2019-10-07
Actual end date 2019-10-07
Shortage status Resolved
Updated date 2019-10-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-08-29 English Compare
v2 2018-08-29 French Compare
v3 2018-09-30 English Compare
v4 2018-09-30 French Compare
v5 2019-01-16 English Compare
v6 2019-01-16 French Compare
v7 2019-02-12 English Compare
v8 2019-02-12 French Compare
v9 2019-03-05 English Compare
v10 2019-03-05 French Compare
v11 2019-04-01 English Compare
v12 2019-04-01 French Compare
v13 2019-04-15 English Compare
v14 2019-04-15 French Compare
v15 2019-06-12 English Compare
v16 2019-06-12 French Compare
v17 2019-07-16 English Compare
v18 2019-07-16 French Compare
v19 2019-08-14 English Compare
v20 2019-08-14 French Compare

Showing 1 to 20 of 24